Verona Pharma plc (VRNA)

Oct 7, 2025 - VRNA was delisted (reason: acquired by MRK)

106.91

+0.12 (0.11%)

Inactive · Last trade price on Oct 6, 2025

Verona Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '25 Oct 3, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	9,215	3,800	1,709	2,133	444	405
Market Cap Growth	278.24%	122.40%	-19.89%	380.79%	9.47%	435.09%
Enterprise Value	9,021	3,587	1,472	1,907	283	205
Last Close Price	106.91	46.44	19.88	26.13	6.72	7.00
PS Ratio	40.39	89.89	-	4657.40	11.09	-
PB Ratio	33.04	18.58	6.85	9.26	3.00	2.19
P/TBV Ratio	33.18	18.63	6.87	9.28	3.01	2.20
EV/Sales Ratio	40.70	84.83	-	4164.23	7.09	-
Debt / Equity Ratio	0.88	1.12	0.21	0.05	0.04	0.03
Asset Turnover	0.44	0.11	-	0.00	0.21	-
Quick Ratio	10.25	10.24	32.53	12.46	4.91	13.82
Current Ratio	10.71	10.63	33.33	12.77	5.09	14.26
Return on Equity (ROE)	-36.36%	-76.42%	-22.67%	-36.30%	-33.39%	-57.25%
Return on Assets (ROA)	-6.68%	-24.13%	-14.64%	-18.53%	-18.45%	-31.68%
Return on Invested Capital (ROIC)	-8.28%	-25.72%	-15.34%	-20.93%	-20.92%	-35.14%
Earnings Yield	-0.88%	-4.56%	-3.18%	-3.22%	-12.53%	-16.07%
FCF Yield	-0.80%	-3.23%	-2.94%	-2.81%	-7.50%	-11.14%
Buyback Yield / Dilution	-4.09%	-2.86%	-19.86%	-11.81%	-79.97%	-149.64%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q